133
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Characterization of the host–guest complex of a curcumin analog with β-cyclodextrin and β-cyclodextrin–gemini surfactant and evaluation of its anticancer activity

, , , , , , , & show all
Pages 503-515 | Published online: 12 Jan 2015

References

  • ParkinJSheaCSantGRIntravesical dimethyl sulfoxide (DMSO) for interstitial cystitis – a practical approachUrology1997495 suppl1051079146010
  • WeissRBHypersensitivity reactions from taxolJ Clin Oncol199087126312681972736
  • MichelDChitandaJMBaloghRDesign and evaluation of cyclodextrin-based delivery systems to incorporate poorly soluble curcumin analogs for the treatment of melanomaEur J Pharm Biopharm201281354855622531300
  • KudoCYamakoshiHSatoASynthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivoBMC Pharmacol201111421619659
  • BillMAFuchsJRLiCThe small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activityMol Cancer2010916520576164
  • MulikRSMönkkönenJJuvonenROMahadikKRParadkarARTransferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosisInt J Pharm20103981–219020320655375
  • BishtSFeldmannGSoniSRaviRKarikarCMaitraAPolymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapyJ Nanobiotechnology20075317439648
  • NagarajuGPAliyaSZafarSFBashaRDiazREl-RayesBFThe impact of curcumin on breast cancerIntegr Biol (United Kingdom)2012499961007
  • NagarajuGPZhuSWenJNovel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancerCancer Lett2013341219520323933177
  • LinYLLiuYKTsaiNMA Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cellsNanomedicine20128331832721704596
  • KunwarABarikAPandeyRPriyadarsiniKITransport of liposomal and albumin loaded curcumin to living cells: an absorption and fluorescence spectroscopic studyBiochim Biophys Acta20061760101513152016904830
  • ChirioDGallarateMPeiraEBattagliaLSerpeLTrottaMFormulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation techniqueJ Microencapsul201128653754821702702
  • KakkarVSinghSSinglaDKaurIPExploring solid lipid nanoparticles to enhance the oral bioavailability of curcuminMol Nutr Food Res201155349550320938993
  • MaZHaddadiAMolaviOLavasanifarALaiRSamuelJMicelles of poly(ethylene oxide)-b-poly(ε-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcuminJ Biomed Mater Res Part A2008862300310
  • TsaiYMChienCFLinLCTsaiTHCurcumin and its nano-formulation: the kinetics of tissue distribution and blood–brain barrier penetrationInt J Pharm2011416133133821729743
  • Seeta Rama RajuGPavitraENagarajuGPRameshKEl-RayesBFYuJSImaging and curcumin delivery in pancreatic cancer cell lines using PEGylated α-Gd2(MoO4)3 mesoporous particlesDalton Trans20144383330333824366050
  • LoftssonTBrewsterMEPharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilizationJ Pharm Sci19968510101710258897265
  • YallapuMMJaggiMChauhanSCβ-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cellsColloids Surf B Biointerfaces201079111312520456930
  • Kazemi-LomedashtFRamiAZarghamiNComparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancerAdv Pharm Bull20133112713024312824
  • BagloleKNBolandPGWagnerBDFluorescence enhancement of curcumin upon inclusion into parent and modified cyclodextrinsJ Photochem Photobiol A Chem20051733 special issue230237
  • TangBMaLWangHYZhangGYStudy on the supramolecular interaction of curcumin and α-cyclodextrin by spectrophotometry and its analytical applicationJ Agric Food Chem20025061355136111879002
  • DandawatePRVyasAAhmadAInclusion complex of novel curcumin analogue CDF and β-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancerPharm Res20122971775178622322899
  • RachmawatiHEdityaningrumCAMauludinRMolecular inclusion complex of curcumin-β-cyclodextrin nanoparticle to enhance curcumin skin permeability from hydrophilic matrix gelAAPS Pharm Sci Tech201314413031312
  • DasUAlcornJShrivastavADesign, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy)phenylcarbonyl]-3,5-bis(arylidene)-4-piperidones and related compoundsEur J Med Chem2007421718016996657
  • HelalMDasUBandyBIslamANazaraliAJDimmockJRMitochondrial dysfunction contributes to the cytotoxicity of some 3,5-bis(benzylidene)-4-piperidone derivatives in colon HCT-116 cellsBioorg Med Chem Lett20132341075107823305919
  • SinghRSPDasUDimmockJRAlcornJA general HPLC-UV method for the quantitative determination of curcumin analogues containing the 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophore in rat biomatricesJ Chromatogr B: Analyt Technol Biomed Life Sci20108782827962802
  • FodjeMJanzenKBergRMxDC and MxLIVE: software for data acquisition, information management and remote access to macromolecular crystallography beamlinesJ Synchrotron Radiat201219227428022338690
  • HammersleyAFIT2D: an introduction and overview European Synchrotron Radiation Facility Internal Report ESRF97HA02T1997
  • TrottaFZanettiMCaminoGThermal degradation of cyclodextrinsPolym Degrad Stab2000693373379
  • ZhuXLWangHBChenQYangWCYangGFPreparation and characterization of inclusion complex of iprodione and β-cyclodextrin to improve fungicidal activityJ Agric Food Chem20075593535353917407323
  • HusseinKTürkMWahlMAComparative evaluation of ibuprofen/β-cyclodextrin complexes obtained by supercritical carbon dioxide and other conventional methodsPharm Res200724358559217260160
  • SongLXGuoXQDuFYBaiLThermal degradation comparison of polypropylene glycol and its complex with β-cyclodextrinPolym Degrad Stab2010954508515
  • AmmarHOSalamaHAGhorabMMahmoudAAFormulation and biological evaluation of glimepiride-cyclodextrin-polymer systemsInt J Pharm20063091–212913816377107
  • CarvalhoRACorreiaHAValenteAJMSödermanONilssonMThe effect of the head-group spacer length of 12-s-12 gemini surfactants in the host-guest association with β-cyclodextrinJ Colloid Interface Sci2011354272573221144532
  • FaustinoCMCCaladoARTGarcia-RioLInteractions between β-cyclodextrin and an amino acid-based anionic gemini surfactant derived from cysteineJ Colloid Interface Sci2012367128629222082803
  • BenkMKirályZThermodynamics of inclusion complex formation of β-cyclodextrin with a variety of surfactants differing in the nature of headgroupJ Chem Thermodyn201254211216
  • LeclercqLNardello-RatajVRauwelGAubryJMStructure-activity relationship of cyclodextrin/biocidal double-tailed ammonium surfactant host-guest complexes: towards a delivery molecular mechanism?Eur J Pharm Sci201041226527520615466
  • QiuXMSunDZWeiXLYinBLThermodynamic study of the inclusion interaction between Gemini surfactants and cyclodextrins by isothermal titration microcalorimetryJ Solution Chem2007363303312
  • Guerrero-MartínezAGonzález-GaitanoGViñasMHTardajosGInclusion complexes between β-cyclodextrin and a gemini surfactant in aqueous solution: an NMR studyJ Phys Chem B200611028138191382816836329
  • GarneroCAiassaVLonghiMSulfamethoxazole: hydroxypropyl-β-cyclodextrin complex: preparation and characterizationJ Pharm Biomed Anal201263747922361661
  • LiSDHuangLNanoparticles evading the reticuloendothelial system: role of the supported bilayerBiochim Biophys Acta20091788102259226619595666
  • LiYWangJWientjesMGAuJLSDelivery of nanomedicines to extracellular and intracellular compartments of a solid tumorAdv Drug Deliv Rev2012641293921569804
  • ConstantinidesPPWasanKMLipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studiesJ Pharm Sci200796223524817051593
  • WettigSDVerrallREFoldvariMGemini surfactants: a new family of building blocks for non-viral gene delivery systemsCurr Gene Ther20088192318336246
  • AlamiEAbrahmsén-AlamiSEastoeJGrilloIHeenanRKInteractions between a nonionic gemini surfactant and cyclodextrins investigated by small-angle neutron scatteringJ Colloid Interface Sci2002255240340912505089
  • NilssonMCabaleiro-LagoCValenteAJMSödermanOInteractions between gemini surfactants, 12-s-12, and β-cyclodextrin as investigated by NMR diffusometry and electric conductometryLangmuir200622218663866917014102
  • ZhangHXLiuYProtein-binding properties of a designed steroidal lactam compoundSteroids201480303624316162
  • DasSDasUMichelDGoreckiDKJDimmockJRNovel 3,5-bis(arylidene)-4-piperidone dimers: Potent cytotoxins against colon cancer cellsEur J Med Chem20136432132823644215
  • KissTFenyvesiFBácskayIEvaluation of the cytotoxicity of β-cyclodextrin derivatives: Evidence for the role of cholesterol extractionEur J Pharm Sci201040437638020434542
  • IrieTUekamaKPharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluationJ Pharm Sci19978621471629040088
  • SilvaSMCSousaJJSMarquesEFPaisAACCMichniak-KohnBBStructure Activity Relationships in Alkylammonium C12-Gemini Surfactants Used as Dermal Permeation EnhancersBMC Biology20131923294804